Scientific Opinions on Migraine - Zomig Rapimelt

Go to navigation
Go to content

Use of Zolmitriptan in Spain: A treatment satisfaction survey

Zolmitriptan orally disintegrating tablet: effective migraine relief and improved ability to perform daily activities in a post-marketing surveillance study

Patient experience influences formulation preference: Results of three prospective studies with zolmitriptan

Zolmitriptan orally disintegrating tablet (ODT) is a highly effective migraine therapy and is preferred over conventional sumatriptan tablets and rizatriptan wafer

Zolmitriptan orally disintegrating tablet (ODT) demonstrates excellent patient and physician satisfaction in primary care migraine therapy

Zolmitriptan 2.5 mg Orally Disintegrating Tablet Achieves High Pain-Free Rates in the Acute Treatment of Migraine: Results of a Randomized, Double-Blind, Placebo-Controlled Study

Patients’ attitudes to migraine - its prevalence, impact and treatment - MAZE* study I and II

Migraine patients prefer zolmitriptan orally disintegrating tablet (ODT) to eletriptan oral tablet

Migraine patients prefer zolmitriptan ODT to eletriptan, sumatriptan and rizatriptan

Effective management of migraine in primary care using a Headache Care for Practicing Clinicians (HCPC) guidelines-based treatment strategy

Pages
1
2
Next

Not signed in

Page tools

Clinical Product Summary